-
Medical journals
- Career
National Colorectal Cancer Screening Program in the Czech Republic – past, presence and future
Authors: M. Zavoral 1; Š. Suchánek 1; O. Májek 2; B. Seifert 3; L. Dušek 2
Authors‘ workplace: Interní klinika, 1. LF UK a ÚVN Praha 1; Institut biostatistiky a analýz, Masarykova univerzita, Brno 2; Ústav všeobecného lékařství, 1. LF UK v Praze 3
Published in: Gastroent Hepatol 2012; 66(5): 345-349
Category: Gastrointestinal Oncology: Review Article
Overview
The National Colorectal Cancer Screening Program in the Czech Republic was introduced in the year 2000. Based on the screening colonoscopy database established in 2006, a precise program evaluation can be performed using internationally respected quality indicators. According to these measures, colonoscopies performed within the screening program have achieved above-average results. The main task for the future is to establish the program on the population level, so the quality can stay at a long-lasting level.
Key words:
colorectal neoplasms – colonoscopy – mass screening – occult blood
The author declares he has no potential conflicts of interest concerning drugs, products, or services used in the study.
The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.Submitted:
26. 9. 2012Accepted:
4. 10. 2012
Sources
1. Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Dostupné z: http://globocan.iarc.fr.
2. Dušek L, Mužík J, Kubásek M et al. Epidemiologie zhoubných nádorů v České republice [online]. Masarykova univerzita, [2005], [cit. 2008-12-15]. Dostupné z: www.svod.cz. Verze 7.0 [2007].
3. Věstník Ministerstva zdravotnictví České republiky, ročník 2009, částka 1.
4. Zavoral M, Suchanek S, Zavada F et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 47(15): 5907–5915.
5. Segnan N, Patnick J, von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis, 1st ed., European Union 2010: 274–297.
6. Singh R, Bourke MJ, Jayanna M et al. Colon tumors and colonoscopy. Gastrointest Endosc 2012; 76(3): 525–530.
7. Panteris V, Haringsma J, Kuipers EJ. Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy. Endoscopy 2009; 41(11): 941–951.
Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery
Article was published inGastroenterology and Hepatology
2012 Issue 5-
All articles in this issue
- Gastrointestinal oncology – near future reality?
- Epidemiology of malignant tumours of the gastrointestinal tract in the Czech Republic – state of the art and prediction
- Reflection on the financial aspects of caring for patients with colorectal carcinoma
- National Colorectal Cancer Screening Program in the Czech Republic – past, presence and future
- Pancreatic cancer
- Endoscopic ablative therapy of the proctosigmoideal neoplastic lesions – a pilot study
- Oesophageal cancer and risk factors by histological type
- Diagnosis and therapy of celiac disease: today and tomorrow
- Non-alcoholic steatohepatitis (NASH) – every physician's concern
- Endoscopy in patients with anticoagulant and antiplatelet therapy
- Guidelines for the administration of aminosalicylatesin patients with inflammatory bowel diseases
- How to improve colorectal cancer screening?
- XXI. Spring Meeting in Loket – advances in the treatment of patients with carcinoma of the pancreas
- Prague Hepatology Meeting 2012
- Prof. MUDr. Aleš Hep, CSc., turned 60
- Budenofalk 2 mg rectal foam represents a major new option in the treatment of patients with ulcerous colitis
- Gastroenterology and Hepatology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Budenofalk 2 mg rectal foam represents a major new option in the treatment of patients with ulcerous colitis
- Epidemiology of malignant tumours of the gastrointestinal tract in the Czech Republic – state of the art and prediction
- Pancreatic cancer
- Prof. MUDr. Aleš Hep, CSc., turned 60
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career